Biopharmaceutical company Rapport Therapeutics, backed by the venture capital arm of Johnson & Johnson, filed for an initial public offering in the United States on Friday.
British drugmaker GSK has raised 1.25 billion pounds ($1.52 billion) from a sale of its remaining stake in consumer healthcare company Haleon to institutional investors.
Cannabis stocks including Tilray, Curaleaf, and the AdvisorShares Pure US Cannabis ETF rallied on Thursday after the U.S.
Johnson & Johnson said on Thursday it would acquire Proteologix for $850 million in cash, as it looks to gain access to the privately held company's experimental atopic dermatitis
Novo Nordisk said on Thursday it was "optimistic" that a fire at a construction site in Kalundborg, Denmark, a key manufacturing hub, would not delay its plans to boost
Pfizer will pay up to $250 million to settle more than 10,000 U.S. lawsuits over cancer risks associated with its discontinued heartburn drug Zantac, the Financial Times reported on
Novo Nordisk does not expect a shortage of its Wegovy weight-loss drug in Denmark despite an earlier warning by the Danish Medicines Agency of strained supply of two separate
Eisai and partner Biogen said on Tuesday that the Japanese drugmaker has begun submitting data on a rolling basis to the US health regulator for a marketing application of a subcutaneous
The International Red Cross and partners are opening a field hospital in southern Gaza on Tuesday to try to meet what it described as "overwhelming" demand for health services since
Walgreens Boots Alliance is in the process of contacting potential buyers to sell its UK-based Boots drugstore chain in a second attempt at separating the unit, Bloomberg News reported on
Tylenol maker Kenvue said on Monday that Johnson & Johnson will sell its remaining 9.5% stake in the company, about a year after the healthcare conglomerate spun off and listed its consumer
Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose
About one in eight adults have taken a drug belonging to the GLP-1 class of medications for weight loss and related conditions, a poll by Kaiser Family Foundation (KFF) showed on Friday.
Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar
The European Commission is planning to allow exemptions from a proposed ban on substances known as PFAS, or "forever chemicals", to
Kenvue will cut 4% of its global workforce amid investments to grow its key brands, the Tylenol and Band-Aid maker said on Tuesday, as it topped beat Wall Street estimates for first-quarter
Vertex Pharmaceuticals beat Wall Street estimates for first-quarter profit on Monday, driven by robust uptake for its blockbuster cystic fibrosis treatments.
Chinese provinces are urging companies to offer women flexible job roles called "Mama's Posts" that make it easier to balance work and childcare, the official Xinhua news agency
Global investment firm KKR will buy Indian medical devices maker Healthium Medtech from UK-based Apax Partners in a deal that three sources with direct knowledge of the
Shares in Danish drugmaker Novo Nordisk dropped as much as 5.3% on Friday, set for their biggest one-day fall since August 2022, after rival Amgen said it was encouraged by interim trial
Illumina reiterated its 2024 revenue forecast on Thursday, expecting continued weak demand from its customers such as medical research labs and hospitals.
French drugmaker Sanofi said on Thursday it would restructure the U.S. commercial operations for its vaccines and cut an undisclosed number of jobs.
Medtech firm Zimmer Biomet Holdings beat Wall Street estimates for first-quarter profit on Thursday, on the back of robust demand for its devices that are used in knee and hip
U.S. drugmaker Regeneron Pharmaceuticals Inc missed Wall Street estimates for quarterly profit on Thursday, hurt by softer sales of its blockbuster eye drug Eylea due to reduction in
Consumer healthcare company Haleon reported first-quarter revenue slightly below market estimates on Wednesday, as volumes declined due to retailer destocking in U.S. and cooling demand for
Hydrogen project investments are accelerating but uncertainty remains, IEA says
What are the key issues in Mozambique elections?
Danish police investigate two blasts near Israel's embassy in Copenhagen
2 predawn explosions rock the area around the Israeli Embassy in Copenhagen but no one is injured
Lebanese emergency services are overwhelmed and need better gear to save lives in wartime
Palestinian officials say 32 killed in Israeli strikes on southern Gaza
Worries over Middle East escalation weigh
Kenya's inflation falls to 3.6% in Sept
Futures in Japan face hangover from BOJ's bond-buying binge
Tatis hits 2-run homer, King strikes out 12 as the Padres beat the Braves 4-0 in playoff opener
Liberty top Aces 88-84 to take a 2-0 lead in the WNBA semifinals and put the champs on the brink
Atlanta rapper Rich Homie Quan died from an accidental drug overdose, medical examiner says